
Results
28
Companies which are undervalued more than 20% based on the Discounted Cash Flow valuation.
28 companies
Jiangsu Hengrui PharmaceuticalsLtd
Market Cap: CN¥366.9b
A pharmaceutical company, researches, develops, manufactures, and commercializes medicines to address unmet clinical needs in China and internationally.
600276
CN¥55.75
7D
2.4%
1Y
-2.0%
WuXi AppTec
Market Cap: CN¥364.1b
An investment holding company, provides research and manufacturing services to discover, develop, and manufacture spectrum for small molecule drugs in the People’s Republic of China, the United States, Europe, and internationally.
603259
CN¥123.30
7D
-0.7%
1Y
59.8%
Zhangzhou Pientzehuang Pharmaceutical
Market Cap: CN¥66.6b
Manufactures and distributes pharmaceuticals and cosmetics in China and internationally.
600436
CN¥117.05
7D
2.5%
1Y
-40.9%
Shanghai Fosun Pharmaceutical (Group)
Market Cap: CN¥55.7b
Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
600196
CN¥23.45
7D
0.7%
1Y
-8.4%
Pharmaron Beijing
Market Cap: CN¥52.1b
Operates as a pharmaceutical research and development service platform in North America, Europe, the Mainland China, Asia, and internationally.
300759
CN¥33.94
7D
14.8%
1Y
25.6%
CSPC Innovation Pharmaceutical
Market Cap: CN¥50.7b
Engages in the research and development, production, and sales of biopharmaceuticals, functional foods, and raw materials in China and internationally.
300765
CN¥38.70
7D
5.4%
1Y
-23.8%
Imeik Technology DevelopmentLtd
Market Cap: CN¥25.9b
Engages in the research and development, and transformation of biomedical materials and biopharmaceutical products in China.
300896
CN¥89.45
7D
-2.4%
1Y
-48.6%
Livzon Pharmaceutical Group
Market Cap: CN¥24.1b
Researches, develops, produces, exports, and sells pharmaceutical products, and active pharmaceutical ingredients (API) and intermediates in the People’s Republic of China and internationally.
000513
CN¥30.24
7D
-0.5%
1Y
-18.2%
MGI Tech
Market Cap: CN¥23.1b
Engages in the research, development, production, and sale of instruments, reagents, and related products for precision medicine, agriculture, healthcare, and other relevant industries in China and internationally.
688114
CN¥56.50
7D
-4.2%
1Y
-10.7%
Chengdu Kanghong Pharmaceutical Group
Market Cap: CN¥20.2b
Engages in the research, development, manufacture, and sale of pharmaceuticals and medical devices in China.
002773
CN¥22.31
7D
-0.1%
1Y
-26.9%
Shenyang Xingqi PharmaceuticalLtd
Market Cap: CN¥14.2b
Engages in the research, development, production, and sale of ophthalmic drugs in the People’s Republic of China.
300573
CN¥40.59
7D
-2.3%
1Y
10.2%
Shenzhen Hepalink Pharmaceutical Group
Market Cap: CN¥12.4b
Shenzhen Hepalink Pharmaceutical Group Co., Ltd.
002399
CN¥9.54
7D
-0.1%
1Y
-21.8%
Nanjing King-Friend Biochemical PharmaceuticalLtd
Market Cap: CN¥11.7b
Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd.
603707
CN¥7.49
7D
-2.0%
1Y
-31.7%
Zhejiang CONBA PharmaceuticalLtd
Market Cap: CN¥10.3b
Engages in the research, development, production, and sales of pharmaceuticals and health products in China.
600572
CN¥4.12
7D
1.0%
1Y
-9.1%
Porton Pharma Solutions
Market Cap: CN¥9.2b
Provides contract development and manufacturing organization (CDMO) solutions for small molecules, tides, biologics, and conjugates from pre-clinical to commercial in China and internationally.
300363
CN¥18.42
7D
9.0%
1Y
-8.8%
AcrobiosystemsLtd
Market Cap: CN¥8.0b
Engages in the development and manufacture of recombinant proteins, antibodies, and other biological reagents for pharmaceutical and biotechnology companies, and research institutions.
301080
CN¥50.60
7D
3.5%
1Y
1.9%
Amoy Diagnostics
Market Cap: CN¥6.5b
Engages in research and development, production, sale, and supporting services of tumor precision medical diagnostic products in China and internationally.
300685
CN¥17.42
7D
-3.2%
1Y
-23.7%
Beijing Strong BiotechnologiesInc
Market Cap: CN¥6.5b
Researches, develops, manufactures, and sells in-vitro diagnostics (IVD) products and services in China and internationally.
300406
CN¥11.23
7D
-2.7%
1Y
-20.5%
Beijing Beilu Pharmaceutical
Market Cap: CN¥4.6b
Engages in the research, development, production, and sale of pharmaceutical products in China.
300016
CN¥8.19
7D
-1.3%
1Y
-11.4%
Getein Biotech
Market Cap: CN¥4.1b
Researches, develops, produces, and sells in vitro diagnostic reagents and instruments in China and internationally.
603387
CN¥8.28
7D
0.1%
1Y
1.1%
Zhejiang Cheng Yi Pharmaceutical
Market Cap: CN¥3.2b
Zhejiang Cheng Yi Pharmaceutical Co., Ltd.
603811
CN¥7.31
7D
-3.8%
1Y
2.0%
Hunan Hansen Pharmaceutical
Market Cap: CN¥3.2b
Engages in the production and sale of traditional Chinese preparations in China and internationally.
002412
CN¥6.00
7D
-0.8%
1Y
-8.8%
Huaren Pharmaceutical
Market Cap: CN¥3.1b
Engages in the research, development, production, and sale of medicines and medical equipment in China and internationally.
300110
CN¥2.69
7D
1.9%
1Y
-20.9%
Guizhou Yibai Pharmaceutical
Market Cap: CN¥2.5b
Researches, develops, produces, and sells novel pharmaceutical products in China.
600594
CN¥3.32
7D
3.8%
1Y
-19.2%
ShanXi C&Y Pharmaceutical GroupLTD
Market Cap: CN¥2.0b
Engages in the research, development, production, and sale of medicine and health food products.
300254
CN¥8.24
7D
-5.0%
1Y
-26.4%
Guhan Pharmaceutical Group
Market Cap: CN¥1.9b
Manufactures and sells traditional Chinese medicines, chemical drugs, and health food under the Guhan brand in China.
000590
CN¥8.19
7D
-5.3%
1Y
-42.7%
Improve Medical Instruments
Market Cap: CN¥1.8b
Engages in the provision of relevant technologies, products, and services for clinical laboratory and clinical nursing in China and internationally.
300030
CN¥6.17
7D
-1.9%
1Y
-20.8%
Guiyang Xintian PharmaceuticalLtd
Market Cap: CN¥1.8b
Engages in the research, development, production, and sale of new traditional Chinese medicines in China.
002873
CN¥7.68
7D
-2.8%
1Y
-21.7%